Cystic Fibrosis Lung Infections: Polymicrobial, Complex, and Hard to Treat.

Cystic Fibrosis Lung Infections: Polymicrobial, Complex, and Hard to Treat.

Bibliographic Details
Main Authors:	Laura M Filkins, George A O'Toole
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-12-01
Series:	PLoS Pathogens
Online Access:	http://europepmc.org/articles/PMC4700991?pdf=render

Similar Items

Cedecea davisae’s Role in a Polymicrobial Lung Infection in a Cystic Fibrosis Patient
by: Thayer G. Ismaael, et al.
Published: (2012-01-01)

Pseudomonas aeruginosa Alters Staphylococcus aureus Sensitivity to Vancomycin in a Biofilm Model of Cystic Fibrosis Infection
by: Giulia Orazi, et al.
Published: (2017-07-01)

Lung infection in cystic fibrosis
by: Hurley, Matthew
Published: (2016)

The process of adhering to aerosol therapy in adolescents with cystic fibrosis : patient and parent perspectives
by: O'Toole, Daniel Patrick Harry
Published: (2012)

Host response to polymicrobial infections in the lung
by: Ji, Yuan
Published: (2019)

Metabolic Modeling of Cystic Fibrosis Airway Communities Predicts Mechanisms of Pathogen Dominance
by: Michael A. Henson, et al.
Published: (2019-04-01)

Lung function and microbiota diversity in cystic fibrosis
by: Leah Cuthbertson, et al.
Published: (2020-04-01)

Polymicrobial lung infection associated with idelalisib administration
by: Eva Lázaro-López, et al.
Published: (2018-01-01)

Bacterial activity in cystic fibrosis lung infections
by: Hockey Peter M, et al.
Published: (2005-06-01)

Ecological networking of cystic fibrosis lung infections
by: Robert A Quinn, et al.
Published: (2016-12-01)

Fostering Innovation in the Treatment of Chronic Polymicrobial Cystic Fibrosis-Associated Infections Exploring Aspartic Acid and Succinic Acid as Ciprofloxacin Adjuvants
by: Eduarda Silva, et al.
Published: (2020-08-01)

Studies on bacterial lung infections in cystic fibrosis
by: Breuleux, Claire Emilie
Published: (2000)

Polymicrobial Interactions in the Cystic Fibrosis Airway Microbiome Impact the Antimicrobial Susceptibility of <i>Pseudomonas aeruginosa</i>
by: Emma Reece, et al.
Published: (2021-07-01)

The surface of Pseudomonas aeruginosa in cystic fibrosis lung infection
by: Cochrane, Doreen M. G.
Published: (1987)

Development of Complex Models to Study Co- and Polymicrobial Infections and Diseases.
by: Glenn Rall, et al.
Published: (2016-09-01)

Epidemiological Features of Chronic Lung Infection in Patients with Cystic Fibrosis
by: I. A. Shaginyan, et al.
Published: (2017-12-01)

Lung clearence index in cystic fibrosis
by: O'Neill, K.
Published: (2014)

Imaging of the bacterial interactions in lung co-infection in cystic fibrosis patients
by: Burkaltseva M.V., et al.
Published: (2020-05-01)

Lung Microbiome in Cystic Fibrosis
by: Filippo Scialo, et al.
Published: (2021-01-01)

Tracking Polymicrobial Metabolism in Cystic Fibrosis Airways: Pseudomonas aeruginosa Metabolism and Physiology Are Influenced by Rothia mucilaginosa-Derived Metabolites
by: Bei Gao, et al.
Published: (2018-04-01)

Inflammatory Markers in Cystic Fibrosis Patients with Lung Pseudomonas Aeruginosa Infection
by: A. L. Pukhalsky, et al.
Published: (1999-01-01)

The Staphylococcus aureus Transcriptome during Cystic Fibrosis Lung Infection
by: Carolyn B. Ibberson, et al.
Published: (2019-11-01)

Early-Life Infection in Cystic Fibrosis and Lung Disease Progression
by: Argyri Petrocheilou MD, et al.
Published: (2017-11-01)

Current and Emerging Therapies to Combat Cystic Fibrosis Lung Infections
by: Jim Manos
Published: (2021-09-01)

Diarrheagenic Pathogens in Polymicrobial Infections
by: Brianna Lindsay, et al.
Published: (2011-04-01)

Oxidant lung injury in cystic fibrosis
by: Chmiel James, et al.
Published: (2000-11-01)

Liposomal clarithromycin delivery for the treatment of pseudomonal lung infection in cystic fibrosis.
by: Alhajlan, Mai Mohsen A.
Published: (2013)

Cyanide toxicity to Burkholderia cenocepacia is modulated by polymicrobial communities and environmental factors
by: Steve P. Bernier, et al.
Published: (2016-05-01)

Prevalence of Polymicrobial Infection in Urethritis
by: Mehmet Sarıer
Published: (2019-09-01)

Hypermutation as an Evolutionary Mechanism for <i>Achromobacter xylosoxidans</i> in Cystic Fibrosis Lung Infection
by: Laura Veschetti, et al.
Published: (2020-01-01)

Update on Respiratory Fungal Infections in Cystic Fibrosis Lung Disease and after Lung Transplantation
by: Sabine Renner, et al.
Published: (2020-12-01)

Achromobacter xylosoxidans airway infection is associated with lung disease severity in children with cystic fibrosis
by: Charlotte Marsac, et al.
Published: (2021-05-01)

An investigation into the antibacterial activites of medicinal plants traditionally used in the Eastern Cape to treat lung infections in cystic fibrosis patients
by: Wilson, Katherine Leigh
Published: (2004)

Practical Guidelines: Lung Transplantation in Patients with Cystic Fibrosis
by: T. O. Hirche, et al.
Published: (2014-01-01)

Concomitant Cryptococcosis and Burkholderia Infection in an Asymptomatic Lung Transplant Patient with Cystic Fibrosis
by: S. Shafaghi, et al.
Published: (2010-10-01)

Longitudinal sampling of the lung microbiota in individuals with cystic fibrosis.
by: Fiona J Whelan, et al.
Published: (2017-01-01)

Mannitol Does Not Enhance Tobramycin Killing of Pseudomonas aeruginosa in a Cystic Fibrosis Model System of Biofilm Formation.
by: Katherine E Price, et al.
Published: (2015-01-01)

Anti-Inflammatory Influences of Cystic Fibrosis Transmembrane Conductance Regulator Drugs on Lung Inflammation in Cystic Fibrosis
by: Kiera H. Harwood, et al.
Published: (2021-07-01)

A Developmental Role of the Cystic Fibrosis Transmembrane Conductance Regulator in Cystic Fibrosis Lung Disease Pathogenesis
by: Elena N. Huang, et al.
Published: (2021-10-01)

A Multi-Faceted Diagnostic Approach to Lung Infections in Patients with Cystic Fibrosis
by: Doud, Melissa S
Published: (2010)

Cannot write session to /tmp/vufind_sessions/sess_outku3ulutlh3s8b3muoopj94v